Brevan Howard Capital Management’s Pacira BioSciences PCRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $660K | Buy |
27,597
+19,495
| +241% | +$466K | ﹤0.01% | 1155 |
|
|
2025
Q1 | $201K | Sell |
8,102
-25,711
| -76% | -$639K | ﹤0.01% | 940 |
|
|
2024
Q4 | $637K | Buy |
+33,813
| New | +$637K | ﹤0.01% | 522 |
|
|
2024
Q2 | – | Sell |
-7,395
| Closed | -$216K | – | 1276 |
|
|
2024
Q1 | $216K | Sell |
7,395
-7,634
| -51% | -$223K | ﹤0.01% | 725 |
|
|
2023
Q4 | $507K | Buy |
+15,029
| New | +$507K | 0.01% | 429 |
|